This protocol addresses the management of primary cervical dystonia. The clinical context and treatment approach covered are summarised below.
The scenario is primary cervical dystonia. Botulinum toxin type A — or type B in cases of resistance to type A — is considered first-line treatment for this condition (level A evidence).
This protocol covers pallidal deep brain stimulation (DBS) as a treatment option for primary cervical dystonia. The complete structured regimen is available via the link below.
BoNT/A (or type B if there is resistance to type A) can be regarded as first-line treatment for primary cranial (excluding oromandibular) or cervical dystonia (level A).
Pallidal DBS can be considered a good option for cervical dystonia, after medication or BoNT has failed to provide adequate improvement (level B).
DOI: 10.1111/j.1468-1331.2010.03042.x
View source ↗